PDCD1 and cancer: However, although control (sgNT) tumors displayed no to very little response to anti-PD-1 treatment, mice engrafted with sgCda cancer cells displayed a tumor reduction of 40% to 70% compared to IgG-treated sgNT controls (Fig. 2b–d and Extended Data Fig. 3h).